Is Shah Capital’s Criticism of Novavax Fair? A Wall Street Analyst Weighs In
In May 2024, Shah Capital, a hedge fund in North Carolina, withdrew from its proxy fight against Novavax’s…
2 Healthcare Stocks to Target This Week and 1 That Underwhelm
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players…